Principal Securities, Inc. Guardant Health, Inc. Transaction History
Principal Securities, Inc.
- $5.32 Trillion
- Q2 2025
A detailed history of Principal Securities, Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 427 shares of GH stock, worth $27,421. This represents 0.0% of its overall portfolio holdings.
Number of Shares
427
Previous 312
36.86%
Holding current value
$27,421
Previous $9.53 Million
133.12%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding GH
# of Institutions
416Shares Held
126MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$781 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$722 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$320 Million0.05% of portfolio
-
Baillie Gifford & CO4.81MShares$309 Million0.2% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$273 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $6.56B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...